TrialPloS one2020

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Gianluigi Giannelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.